National Health (Botulinum Toxin Program) Special Arrangement 2011 (No. PB 89 of 2011)
25Payments for supply of botulinum toxin pharmaceutical benefit
Start here
Get a plain-English read of 25
Turn the raw legal text into a practical explanation grounded in National Health (Botulinum Toxin Program) Special Arrangement 2011 (No. PB 89 of 2011).
25 Payments for supply of botulinum toxin pharmaceutical benefit
(1) If the requirements of subsection (2) have been met, a responsible person who makes a claim for payment under subsection 24(1) is entitled to be paid the ex‑manufacturer price for the botulinum toxin pharmaceutical benefit. (2) The Chief Executive Medicare may only make a payment for the supply of a botulinum toxin pharmaceutical benefit in a treatment period if the Chief Executive Medicare has: (a) received, from the eligible medical practitioner, the documents mentioned in subsection 22(1); and (b) received, from the responsible person for the botulinum toxin pharmaceutical benefit supplied to the eligible medical practitioner, the documents mentioned in subsection 24(1); and (c) verified that the botulinum toxin pharmaceutical benefit has been supplied in accordance with the requirements of this Special Arrangement.